Tag Archives: BioPlus

January, 2016

  • 13 January

    The MS Game Changer

    A new medication for multiple sclerosis made waves when research about its effectiveness debuted at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) back in October 2015. Now experts are calling this medication one of the greatest developments of the past year for the …

December, 2015

  • 30 December

    Benefits of Tight Control

    Psoriasis, a type of autoimmune disease, afflicts more than 7.5 million Americans, causing itchy or sore patches of thick, reddened skin covered with silvery scales. While this disease is most likely to develop in people 15-25 years old, after about a decade of having psoriasis, some people also develop psoriatic …

  • 28 December

    The Promise of Pan-Genotype Cure

    One treatment which works against all strains of the hepatitis C virus (HCV) appears to be getting closer to reality all the time, as I wrote about on October 20, 2015 in One Pill for All Hepatitis C Strains. Gilead Sciences’ Sovaldi (sofosbuvir) combined in one pill with an NS5A inhibitor called …

  • 15 December

    Hepatitis C: Looking Beyond the Liver

    The liver is, understandably, ground zero when it comes to the hepatitis C virus (HCV). However, other body organs are not without consequences from this disease. There is a strong association between hepatitis C and chronic kidney disease. This combination of HCV and kidney disease presents challenges for treatment, since …

  • 9 December

    Who Isn’t Taking Their Cancer Medication?

    Just a few years ago, a physician knew immediately if a patient didn’t follow the prescribed cancer treatment, because the treatment was likely given intravenously at a health care facility. If the patient missed a scheduled appointment, then the physician could work to get the patient back in compliance. Today, …

  • 2 December

    Hepatitis C Deaths Still On Rise

    The headlines are compelling when it comes to new medications for treating infection with the hepatitis C virus (HCV): Harvoni cures up to 98% of patients with genotype 1 HCV. Viekira Pak cures 100% of those with genotype 1b HCV. Sovaldi cures 95% of those with genotype 2 HCV. With …

November, 2015

  • 24 November

    HIV Treatment Choices Expand

    More than 1.2 million Americans live with HIV infection and one in eight has not yet been diagnosed, according to the Centers for Disease Control and Prevention. Despite public health initiatives, each year approximately 50,000 more Americans are infected with this virus. There is now a new medication available to …

  • 17 November

    Not Just for Hollywood

    Hepatitis C cures were back in the news last week, when Pamela Anderson joyfully shared that she is cured of hepatitis C after taking one of the new medications for this disease. This actress was first diagnosed 16 years ago and believes that she contracted this life-threatening disease from a …

  • 10 November

    Guided by Fibrosis Stage

    When to start treatment for hepatitis C can be a hotly debated topic, with sicker patients generally moved to the front of the line. However, the question remains: “how can we identify who are the ‘sicker patients’?” An effective way to identify which hepatitis C patients should get the most …

  • 3 November

    The Next Wave of Hepatitis C

    Despite a few years of good news with hepatitis C – with several new medications bringing cure rates up to 99% – there is also some bad news that must be acknowledged. Hepatitis C infection rates are actually rising in certain populations. The most at-risk population experiencing this hepatitis C …